US4172896A
(en)
|
1978-06-05 |
1979-10-30 |
Dainippon Pharmaceutical Co., Ltd. |
Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
|
JPS60243083A
(ja)
|
1984-05-18 |
1985-12-03 |
Nissan Chem Ind Ltd |
ピラゾ−ルスルホニルウレア誘導体、その製法および該誘導体を含有する除草剤
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
US5569655A
(en)
|
1993-09-14 |
1996-10-29 |
Sterling Winthrop Inc. |
Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
|
TW401301B
(en)
|
1994-10-07 |
2000-08-11 |
Takeda Chemical Industries Ltd |
Antihypertriglyceridemic composition
|
AR002459A1
(es)
|
1995-01-17 |
1998-03-25 |
American Cyanamid Co |
Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
|
US5849735A
(en)
|
1995-01-17 |
1998-12-15 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
PT999825E
(pt)
|
1997-07-29 |
2004-02-27 |
Alcon Lab Inc |
Composicoes oftalmicas contendo polimeros de galactomanano e borato
|
AU2483599A
(en)
|
1998-01-29 |
1999-08-16 |
Sepracor, Inc. |
Pharmaceutical uses of optically pure (-)-bupropion
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
CA2400181C
(en)
|
2000-12-20 |
2008-08-05 |
Kyowa Hakko Kogyo Co., Ltd. |
Metal complex type squarylium compounds and optical recording media made by using the same
|
DE10239042A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
EP2325224A1
(en)
|
2002-10-30 |
2011-05-25 |
Sumitomo Chemical Company, Limited |
Aryl copolymer compounds and polymer light emitting devices made by using the same
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
EP2113246B1
(en)
|
2003-08-07 |
2016-06-22 |
Allergan, Inc. |
Compositions for delivery of therapeutics into the eyes and methods for making and using the same
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
US7514466B2
(en)
|
2004-04-27 |
2009-04-07 |
Wyeth |
Purification of progesterone receptor modulators
|
PE20060331A1
(es)
|
2004-04-27 |
2006-05-16 |
Wyeth Corp |
Proceso de acoplamiento para la generacion de derivados reactivos de pirrol-2-carbonitrilo n-sustituidos con contenido de boro para producir biarilos
|
DOP2005000123A
(es)
|
2004-07-02 |
2011-07-15 |
Merck Sharp & Dohme |
Inhibidores de cetp
|
US7338973B2
(en)
|
2004-09-20 |
2008-03-04 |
Janssen Pharmaceutica N.V. |
Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
|
US7445211B1
(en)
|
2005-03-11 |
2008-11-04 |
Walton Daniel J |
Wall decoration and game apparatus
|
US20070116984A1
(en)
|
2005-09-21 |
2007-05-24 |
Doosan Corporation |
Spiro-compound for electroluminescent display device and electroluminescent display device comprising the same
|
US20090022694A1
(en)
|
2005-10-18 |
2009-01-22 |
Distefano Peter |
Sirt1 inhibition
|
GB0526044D0
(en)
|
2005-12-21 |
2006-02-01 |
Syngenta Ltd |
Novel herbicides
|
KR20150013941A
(ko)
|
2006-02-16 |
2015-02-05 |
아나코르 파마슈티칼스 인코포레이티드 |
항염증제로서 보론함유 소분자
|
GB0603891D0
(en)
|
2006-02-27 |
2006-04-05 |
Syngenta Ltd |
Novel herbicides
|
US20070213526A1
(en)
|
2006-03-07 |
2007-09-13 |
Wyeth |
Purification of progesterone receptor modulators
|
GB0609492D0
(en)
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
US7915414B2
(en)
|
2006-11-24 |
2011-03-29 |
Yun Chi |
Blue-emitting organometallic complexes and their application
|
FR2913882B1
(fr)
|
2007-03-20 |
2009-05-01 |
Oreal |
Utilisation pour la coloration des fibres keratiniques d'une composition comprenant un compose halochromique et/ou le colorant correspondant a ce compose
|
JP5492769B2
(ja)
|
2007-06-26 |
2014-05-14 |
サノフイ |
縮環されたベンゾイミダゾール及びアザベンゾイミダゾールの位置選択的金属触媒合成
|
AU2008272693A1
(en)
|
2007-07-02 |
2009-01-08 |
Astrazeneca Ab |
3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents
|
US9446995B2
(en)
|
2012-05-21 |
2016-09-20 |
Illinois Institute Of Technology |
Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
|
US10189803B2
(en)
|
2008-02-22 |
2019-01-29 |
Illinois Institute Of Technology |
Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
|
CA2718170A1
(en)
|
2008-03-06 |
2009-09-11 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules as anti-inflammatory agents
|
JP2009234928A
(ja)
|
2008-03-25 |
2009-10-15 |
Kyoto Univ |
縮合多環芳香族化合物、およびその製造方法
|
JP5304010B2
(ja)
|
2008-04-23 |
2013-10-02 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
JP5499519B2
(ja)
|
2009-05-27 |
2014-05-21 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
SG177654A1
(en)
|
2009-08-04 |
2012-02-28 |
Tokuyama Corp |
Chromene compound
|
JP4599469B1
(ja)
|
2009-08-31 |
2010-12-15 |
富士フイルム株式会社 |
有機電界発光素子用材料及び有機電界発光素子
|
US8410091B1
(en)
|
2009-09-11 |
2013-04-02 |
Boehringer Ingelheim International Gmbh |
Process for preparation of substituted 2-amino-5-(5-(heterocyclemethyl)pyridin-2-yloxy)benzoic acid
|
US20110071136A1
(en)
|
2009-09-16 |
2011-03-24 |
Cylene Pharmaceuticals, Inc |
Novel tricyclic protein kinase modulators
|
EP2566858A2
(en)
|
2010-05-04 |
2013-03-13 |
Pfizer Inc. |
Heterocyclic derivatives as alk inhibitors
|
EP2598510A4
(en)
|
2010-07-30 |
2014-02-26 |
Reddys Lab Ltd Dr |
LIGANDS FOR SELECTIVE ASYMMETRIC HYDROFORMYLATION
|
US20120157448A1
(en)
|
2010-11-22 |
2012-06-21 |
Adam Cook |
Compounds for treating neurodegenerative diseases
|
AU2011336214B2
(en)
|
2010-12-01 |
2015-08-20 |
Pfizer Inc. |
KAT II inhibitors
|
ES2559519T3
(es)
|
2010-12-22 |
2016-02-12 |
Université Catholique de Louvain |
Nuevos derivados de fenazina y su uso
|
WO2012089633A1
(fr)
|
2010-12-28 |
2012-07-05 |
Sanofi |
Nouveaux derives de pyrimidines, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt(pkb)
|
FR2969611B1
(fr)
|
2010-12-28 |
2013-02-08 |
Sanofi Aventis |
Nouveaux derives de thiazoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de phosphorylation d'akt(pkb)
|
WO2012102409A1
(ja)
|
2011-01-27 |
2012-08-02 |
株式会社トクヤマ |
クロメン化合物
|
WO2012138648A1
(en)
|
2011-04-06 |
2012-10-11 |
Irm Llc |
Compositions and methods for modulating lpa receptors
|
EP2705039B1
(en)
|
2011-05-04 |
2017-07-26 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
CN102408385B
(zh)
|
2011-06-20 |
2014-06-18 |
雅本化学股份有限公司 |
一种2-取代-2h-1,2,3-三氮唑衍生物的制备方法
|
TW201311689A
(zh)
|
2011-08-05 |
2013-03-16 |
必治妥美雅史谷比公司 |
作為因子xia抑制劑之新穎巨環化合物
|
TWI506030B
(zh)
|
2011-09-06 |
2015-11-01 |
Nat Univ Tsing Hua |
含有碳烯配位基的過渡金屬錯合物結構及其在發光材料的應用
|
CN104271574B
(zh)
|
2012-02-20 |
2017-01-25 |
武田药品工业株式会社 |
杂环化合物
|
CN102603659B
(zh)
|
2012-03-01 |
2014-03-26 |
雅本化学股份有限公司 |
1-取代-4-溴-1h-1,2,3-三氮唑-5-羧酸及其制备方法
|
BR112014022106B1
(pt)
|
2012-03-06 |
2022-08-02 |
Pfizer Inc |
Derivados macrocíclicos, combinação, composição e usos na fabricação de um medicamento para o tratamento de doenças
|
KR20140032823A
(ko)
|
2012-09-07 |
2014-03-17 |
롬엔드하스전자재료코리아유한회사 |
유기 전계 발광 소자
|
JP6199752B2
(ja)
|
2013-01-24 |
2017-09-20 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子用材料及びそれを用いた有機エレクトロルミネッセンス素子、並びに含窒素複素環化合物
|
WO2014138912A1
(en)
|
2013-03-13 |
2014-09-18 |
Queen's University At Kingston |
Luminescent compounds and methods of using same
|
US9637500B2
(en)
|
2013-06-28 |
2017-05-02 |
Pfizer Inc. |
Solid forms of a macrocyclic kinase inhibitor
|
US10273224B2
(en)
|
2013-08-22 |
2019-04-30 |
Jubilant Biosys Limited |
Substituted pyrimidine compounds, compositions and medicinal applications thereof
|
KR102100929B1
(ko)
|
2013-09-04 |
2020-04-14 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
CN104513253A
(zh)
|
2013-10-01 |
2015-04-15 |
南京波尔泰药业科技有限公司 |
用于治疗增殖性疾病的大环化合物
|
US20160256448A1
(en)
|
2013-11-18 |
2016-09-08 |
Forma Therapeutics, Inc. |
Tetrahydroquinoline compositions as bet bromodomain inhibitors
|
WO2015074064A2
(en)
|
2013-11-18 |
2015-05-21 |
Bair Kenneth W |
Tetrahydroquinoline compositions as bet bromodomain inhibitors
|
KR102167048B1
(ko)
|
2013-12-03 |
2020-10-19 |
삼성디스플레이 주식회사 |
화합물 및 이를 포함한 유기 발광 소자
|
ES2902835T3
(es)
|
2014-01-09 |
2022-03-30 |
Hadasit Med Res Service |
Composiciones celulares mejoradas y métodos para la terapia contra el cáncer
|
KR102191992B1
(ko)
|
2014-01-22 |
2020-12-17 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
KR102253441B1
(ko)
|
2014-03-10 |
2021-05-20 |
삼성디스플레이 주식회사 |
화합물 및 이를 포함한 유기 발광 소자
|
CN105130966B
(zh)
|
2014-05-07 |
2019-05-24 |
广东东阳光药业有限公司 |
炔基化合物及其使用方法和用途
|
WO2015175579A1
(en)
|
2014-05-15 |
2015-11-19 |
Calitor Sciences, Llc |
Alkynyl compounds and methods of use
|
WO2016026423A1
(en)
*
|
2014-08-20 |
2016-02-25 |
Teligene Ltd |
Substituted macrocycles useful as kinases inhibitors and methods of use thereof
|
KR101793335B1
(ko)
|
2014-09-30 |
2017-11-02 |
주식회사 엘지화학 |
헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
|
CN105585534B
(zh)
|
2014-10-23 |
2018-05-18 |
上海雅本化学有限公司 |
一种1-取代-1h-1,2,3-三氮唑-4-羧酸的制备方法
|
US20160140491A1
(en)
|
2014-11-17 |
2016-05-19 |
Gregory Forgatch |
System and method for integrating intermediary and end-user online retail experiences
|
IL295547A
(en)
|
2015-01-22 |
2022-10-01 |
Myokardia Inc |
Piperidine-4-methylsulfonyl-modified urea compounds for the treatment of dilated cardiomyopathy (dcm)
|
US9887372B2
(en)
|
2015-06-11 |
2018-02-06 |
Samsung Display Co., Ltd. |
Amine-based compound and organic light-emitting device including the same
|
MX2018001173A
(es)
|
2015-08-03 |
2018-04-24 |
Squibb Bristol Myers Co |
Compuestos ciclicos utiles como moduladores del factor de necrosis tumoral (tnf) alfa.
|
WO2017080980A1
(en)
|
2015-11-09 |
2017-05-18 |
Astrazeneca Ab |
Dihydropyrrolopyrazinone derivatives useful in the treatment of cancer
|
JP7100362B2
(ja)
|
2015-11-13 |
2022-07-13 |
ドメイン・セラピューティクス |
グループii代謝型グルタミン酸受容体のアロステリックモジュレーターとしての置換三環式1,4-ベンゾジアゼピノン誘導体
|
EP3380479B1
(en)
|
2015-11-25 |
2022-12-07 |
Gilead Apollo, LLC |
Triazole acc inhibitors and uses thereof
|
CN105669733A
(zh)
|
2016-01-29 |
2016-06-15 |
上海毕路得医药科技有限公司 |
一种1-甲基-1h-吡唑-3-硼酸频哪醇酯的合成方法
|
WO2017148325A1
(zh)
|
2016-03-03 |
2017-09-08 |
深圳市塔吉瑞生物医药有限公司 |
一种大环化合物及包含该化合物的组合物
|
CN106243096B
(zh)
|
2016-07-29 |
2019-11-29 |
上海璃道医药科技有限公司 |
三环类药物的新用途
|
JP6798851B2
(ja)
|
2016-10-14 |
2020-12-09 |
株式会社トクヤマ |
クロメン化合物、及び該クロメン化合物を含む硬化性組成物
|
US10954215B2
(en)
|
2016-12-13 |
2021-03-23 |
Boehringer Ingelheim International Gmbh |
Compounds as modulators of ROR gamma
|
CN109528717B
(zh)
|
2017-09-21 |
2021-08-17 |
中国科学院分子细胞科学卓越创新中心 |
治疗或预防肥胖或其相关疾病的化合物及其应用
|
JOP20180092A1
(ar)
|
2017-10-13 |
2019-04-13 |
Gilead Sciences Inc |
مثبطات hiv بروتياز
|
US20210283261A1
(en)
|
2017-12-05 |
2021-09-16 |
Icahn School Of Medicine At Mount Sinai |
Compositions and Methods for Treating ALK-Mediated Cancer
|
US11680059B2
(en)
|
2017-12-21 |
2023-06-20 |
Guangzhou Chinaray Optoelectronic Materials Ltd. |
Organic mixture and application thereof in organic electronic devices
|
WO2019149131A1
(zh)
*
|
2018-01-30 |
2019-08-08 |
上海吉倍生物技术有限公司 |
具有大环分子结构的化合物及其用途
|
KR20200119272A
(ko)
|
2018-02-11 |
2020-10-19 |
장쑤 한서 파마슈티칼 그룹 캄파니 리미티드 |
스테로이드 유도체 조절제, 그 제조 방법 및 그의 용도
|
WO2019164301A1
(ko)
|
2018-02-21 |
2019-08-29 |
주식회사 엘지화학 |
화합물 및 이를 포함하는 유기 발광 소자
|
KR102192368B1
(ko)
|
2018-02-28 |
2020-12-17 |
주식회사 엘지화학 |
유기 발광 소자
|
CN110357905B
(zh)
|
2018-03-26 |
2021-10-01 |
武汉誉祥医药科技有限公司 |
作为蛋白激酶抑制剂的大环类衍生物及其制备方法和用途
|
CN108912175A
(zh)
|
2018-06-05 |
2018-11-30 |
长春海谱润斯科技有限公司 |
一种金属铱配合物及其有机发光器件
|
CN112771035A
(zh)
|
2018-07-26 |
2021-05-07 |
恩特姆生物科学公司 |
用于制备甘露糖衍生物的方法
|
US10593889B1
(en)
|
2018-09-26 |
2020-03-17 |
Idemitsu Kosan Co., Ltd. |
Compound and organic electroluminescence device
|
EP3856192A4
(en)
|
2018-09-27 |
2023-01-04 |
Dana Farber Cancer Institute, Inc. |
ALK-TARGETING DEGRADING AGENTS AND THEIR THERAPEUTIC USES
|
EP3873892A1
(en)
|
2018-10-30 |
2021-09-08 |
Bristol-Myers Squibb Company |
Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of il-12, il-23 and/or ifn-alpha
|
CN109912433B
(zh)
|
2019-03-07 |
2022-04-08 |
石家庄诚志永华显示材料有限公司 |
化合物、有机电致发光材料、有机电致发光器件、电子装置
|
KR20200111577A
(ko)
|
2019-03-19 |
2020-09-29 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
CN112533927A
(zh)
|
2019-05-14 |
2021-03-19 |
苏州韬略生物科技有限公司 |
可用作激酶抑制剂的被取代的大环
|
CN114207861A
(zh)
|
2019-08-02 |
2022-03-18 |
德山新勒克斯有限公司 |
有机电子器件
|
CN112321604A
(zh)
|
2019-08-05 |
2021-02-05 |
华东理工大学 |
大环类jak2抑制剂及其应用
|
GB201913756D0
(en)
|
2019-09-24 |
2019-11-06 |
Chromatwist Ltd |
Contrast agent
|
CN114502564A
(zh)
|
2019-09-26 |
2022-05-13 |
贝达药业股份有限公司 |
Egfr抑制剂、组合物及其制备方法
|
WO2021062327A1
(en)
|
2019-09-27 |
2021-04-01 |
Jubilant Biosys Limited |
Fused pyrimidine compounds, compositions and medicinal applications thereof
|
CN110734456A
(zh)
|
2019-11-06 |
2020-01-31 |
南京谷睿生物科技有限公司 |
一种化合物及其制备方法和医药上的应用
|
WO2021097039A1
(en)
|
2019-11-15 |
2021-05-20 |
Gilead Sciences, Inc. |
Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof
|
CN112812128B
(zh)
|
2019-11-18 |
2024-04-02 |
正大天晴药业集团股份有限公司 |
作为alk和ros调节剂的大环化合物
|
EP4079740A4
(en)
|
2019-12-16 |
2023-06-07 |
I-Sens, Inc. |
NEW TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIOSENSOR USING IT
|
TW202136246A
(zh)
|
2019-12-19 |
2021-10-01 |
德商麥克專利有限公司 |
電子裝置用化合物
|
CN113121607B
(zh)
|
2019-12-31 |
2023-07-04 |
马鞍山南大高新技术研究院有限公司 |
一种主配体含喹啉/喹唑啉的红光铱配合物与应用
|
IL296790A
(en)
|
2020-03-30 |
2022-11-01 |
Hutchison Medipharma Ltd |
Amide compounds and their uses
|
CN111440154B
(zh)
|
2020-04-24 |
2022-04-19 |
梯尔希(南京)药物研发有限公司 |
一种替格列汀二聚体杂质的合成方法
|
CN111362967B
(zh)
|
2020-04-28 |
2021-09-07 |
南京雷正医药科技有限公司 |
苯并氧杂二氮杂十四碳烯衍生物及其用途
|
EP4146205A4
(en)
|
2020-05-05 |
2024-05-29 |
Nuvalent, Inc. |
HETEROAROMATIC MACROCYCLIC ETHER-BASED CHEMOTHERAPY AGENTS
|
CA3179700A1
(en)
|
2020-05-05 |
2021-11-11 |
Nuvalent, Inc. |
Heteroaromatic macrocyclic ether chemotherapeutic agents
|
JP2023523863A
(ja)
|
2020-05-06 |
2023-06-07 |
レ ラボラトワール セルヴィエ |
新規大環状lrrk2キナーゼインヒビター
|
WO2021233296A1
(zh)
|
2020-05-18 |
2021-11-25 |
深圳市塔吉瑞生物医药有限公司 |
大环化合物的固体形式及其制备和用途
|
JP2023529369A
(ja)
|
2020-06-03 |
2023-07-10 |
ギリアード サイエンシーズ, インコーポレイテッド |
Lpa受容体アンタゴニスト及びそれらの使用
|
TWI838626B
(zh)
|
2020-06-03 |
2024-04-11 |
美商基利科學股份有限公司 |
Lpa受體拮抗劑及其用途
|
WO2022194399A1
(en)
|
2020-07-13 |
2022-09-22 |
Idorsia Pharmaceuticals Ltd |
Macrocycles as cftr modulators
|
WO2022017408A1
(zh)
|
2020-07-22 |
2022-01-27 |
中国医药研究开发中心有限公司 |
芳胺类衍生物及其制备方法和医药用途
|
CN111808147B
(zh)
|
2020-07-28 |
2023-04-18 |
奥来德(上海)光电材料科技有限公司 |
一种有机磷光材料及其制备方法和电致发光器件
|
EP4294808A1
(en)
|
2021-02-19 |
2023-12-27 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
WO2022198196A1
(en)
|
2021-03-15 |
2022-09-22 |
Maze Therapeutics, Inc. |
Inhibitors of glycogen synthase 1 (gys1) and methods of use thereof
|
WO2022212538A1
(en)
|
2021-03-31 |
2022-10-06 |
Blueprint Medicines Corporation |
Diazepanone-fused pyrimidine compounds, compositions and medicinal applications thereof
|
CN113105440B
(zh)
|
2021-04-15 |
2022-10-04 |
吉林奥来德光电材料股份有限公司 |
一种有机电致发光化合物及其制备方法和应用
|
AU2022273702A1
(en)
|
2021-05-13 |
2023-11-02 |
Gilead Sciences, Inc. |
Lpa receptor antagonists and uses thereof
|
IL308421A
(en)
|
2021-05-14 |
2024-01-01 |
Bristol Myers Squibb Co |
substituted heterocyclic compounds
|
WO2023056405A1
(en)
|
2021-10-01 |
2023-04-06 |
Nuvalent, Inc. |
Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds
|
IL311387A
(en)
|
2021-10-01 |
2024-05-01 |
Nuvalent Inc |
Methods for solid tumor treatment using macrocyclic heteroaromatic ether compounds
|
WO2023059801A1
(en)
|
2021-10-06 |
2023-04-13 |
The Regents Of The University Of Colorado, A Body Corporate |
Biomarkers for egfr-mediated resistance in oncogene-driven cancers and methods of treating, preventing, and/or ameliorating oncogene-driven cancers
|
WO2023179600A1
(zh)
|
2022-03-21 |
2023-09-28 |
杭州德睿智药科技有限公司 |
新型取代大杂环类新化合物及其应用
|
US20230322797A1
(en)
|
2022-04-07 |
2023-10-12 |
Nuvalent, Inc. |
Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds
|